Effect of reducing portion size at a compulsory meal on later energy intake, gut hormones, and appetite in overweight adults

Obesity

Volumn 23, Issue 7, 2015, Pages 1362-1370

  Lewis, Hannah B ^a   Ahern, Amy L ^a   Solis Trapala, Ivonne ^a   Walker, Celia G ^a   Reimann, Frank ^b   Gribble, Fiona M ^b   Jebb, Susan A ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; INSULIN; PEPTIDE YY;

ADULT; APPETITE; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUNGER; MALE; OBESITY; PORTION SIZE; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SATIETY; VISUAL ANALOG SCALE; ADOLESCENT; BLOOD; DIET; MEAL; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; APPETITE; CROSS-OVER STUDIES; DIET; ENERGY INTAKE; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HUNGER; INSULIN; MALE; MEALS; MIDDLE AGED; OVERWEIGHT; PEPTIDE YY; PORTION SIZE; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84933178589     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21105     Document Type: Article

References (40)

1. Nielsen SJ, Popkin BM,. Patterns and trends in food portion sizes, 1977-1998. JAMA 2003; 289: 450-453.
2. Young LR, Nestle M,. The contribution of expanding portion sizes to the US obesity epidemic. Am J Public Health 2002; 92: 246-249.
3. Rolls BJ, Morris EL, Roe LS,. Portion size of food affects energy intake in normal-weight and overweight men and women. Am J Clin Nutr 2002; 76: 1207-1213.
4. Rolls BJ, Roe LS, Meengs JS,. The effect of large portion sizes on energy intake is sustained for 11 days. Obesity 2007; 15: 1535-1543.
5. Prentice A, Jebb S,. Energy intake/physical activity interactions in the homeostasis of body weight regulation. Nutr Rev 2004; 62: S98-S104.
6. Scientific Advisory Committee on Nutrition (2011). Dietary Reference Values for Energy. London: TSO. [www document] Available at: URL: http://www.sacn.gov.uk/reports-position
7. Garner DM, Garfinkel PE,. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273-279.
8. Orbitello B, Ciano R, Corsaro M, et al., The EAT-26 as screening instrument for clinical nutrition unit attenders. Int J Obes 2006; 30: 977-981.
9. Zung WWK,. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
10. The IPAQ Group. International Physical Activity Questionnaire. [www document] Available at: URL: https://sites.google.com/site/theipaq/
11. Kral TVE, Roe LS, Rolls BJ,. Combined effects of energy density and portion size on energy intake in women. Am J Clin Nutr 2004; 79: 962-968.
12. Doucet E, Laviolette M, Imbeault P, Strychar I, Rabasa-Lhoret R, Prud'homme D,. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women. Metabolism 2008; 57: 1458-1464.
13. Stunkard AJ, Messick S,. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29: 71-83.
14. Food Standards Agency and Department of Health (2010). National Diet and Nutrition Survey: Headline results from Year 1 of the Rolling Programme (2008/2009). [www document] Available at: URL: http://www.food.gov.uk/multimedia/pdfs/publication/ndnsreport0809year1results.pdf
15. Fitt E, Cole D, Ziauddeen N, et al., DINO (Diet In Nutrients Out)-an integrated dietary assessment system. Public Health Nutrition 2014; 27: 1-8.
16. McCulloch C, Searle S., Generalized Linear and Mixed Models. New York: Wiley; 2000.
17. le Roux CW, Batterham RL, Aylwin SJB, et al., Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006; 147: 3-8.
18. Martins C, Robertson MD, Morgan LM,. Impact of restraint and disinhibition on PYY plasma levels and subjective feelings of appetite. Appetite 2010; 55: 208-213.
19. Vilsbøll T, Krarup T, Sonne J, et al., Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003; 88: 2706-2713.
20. Rijkelijkhuizen JM, McQuarrie K, Girman CJ, et al., Effects of meal size and composition on incretin, α-cell, and β-cell responses. Metabolism 2010; 59: 502-511.
21. Borer KT, Wuorinen E, Ku K, Burant C,. Appetite responds to changes in meal content, whereas ghrelin, leptin, and insulin track changes in energy availability. J Clin Endocrinol Metab 2009; 94: 2290-2298.
22. Blom WAM, Stafleu A, de Graaf C, Kok FJ, Schaafsma G, Hendriks HFJ,. Ghrelin response to carbohydrate-enriched breakfast is related to insulin. Am J Clin Nutr 2005; 81: 367-375.
23. Colman AM., Oxford Dictionary of Psychology, 3rd ed. Oxford: Oxford University Press; 2009.
24. Flint A, Moller BK, Raben A, et al., Glycemic and insulinemic responses as determinants of appetite in humans. Am J Clin Nutr 2006; 84: 1365-1373.
25. Willbond SM, Doucet E,. Individually timing high-protein preloads has no effect on daily energy intake, peptide YY and glucagon-like peptide-1. Eur J Clin Nutr 2011; 65: 55-62.
26. Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A,. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes 2001; 25: 1206-1214.
27. Drapeau V, King N, Hetherington M, Doucet E, Blundell J, Tremblay A,. Appetite sensations and satiety quotient: predictors of energy intake and weight loss. Appetite 2007; 48: 159-166.
28. Lemmens SG, Martens EA, Born JM, Martens MJ, Westerterp-Plantenga MS,. Staggered meal consumption facilitates appetite control without affecting postprandial energy intake. J Nutr 2011; 141: 482-488.
29. Holt SHA, Miller JCB, Petocz P,. Interrelationships among postprandial satiety, glucose and insulin responses and changes in subsequent food intake. EurJ Clin Nutr 1996; 50: 788-797.
30. Gray RW, French SJ, Robinson TM, Yeomans MR,. Dissociation of the effects of preload volume and energy content on subjective appetite and food intake. Physiol Behav 2002; 76: 57-64.
31. De Graaf C, Hulshof T,. Effects of weight and energy content of preloads on subsequent appetite and food intake. Appetite 1996; 26: 139-151.
32. Stubbs RJ, Hughes DA, Johnstone AM, et al., The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000; 84: 405-415.
33. Batterham RL, Cohen MA, Ellis SM, et al., Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-948.
34. Sloth B, Holst JJ, Flint A, Gregersen NT, Astrup A,. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endoc M 2007; 292: E1062-E1068.
35. Brennan IM, Luscombe-Marsh ND, Seimon RV, et al., Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. Am J Physiol Gastr L 2012; 303: G129-G140.
36. Lemmens SG, Martens EA, Kester AD, Westerterp-Plantenga MS,. Changes in gut hormone and glucose concentrations in relation to hunger and fullness. Am J Clin Nutr 2011; 94: 717-725.
37. Blundell JE, Levin F, King NA, et al., Overconsumption and obesity: peptides and susceptibility to weight gain. Regul Pept 2008; 149: 32-38.
38. Gibbons C, Caudwell P, Finlayson G, et al., Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J Clin Endocrinol Metab 2013; 98: E847-E855.
39. Guo Y, Ma LJ, Enriori PJ, et al., Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans. Obesity 2006; 14: 1562-1570.
40. Paschetta E, Hvalryg M, Musso G,. Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders. Obes Rev 2011; 12: 813-828.